Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients
Authors:
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 17 (7) , 415-423
Abstract
No abstract availableKeywords
Funding Information
- Postdoctoral Science Foundation of China (2015M580270)
- Postdoctoral Science Foundation of Heilongjiang Province (LBH-Z15129)
- Harbin Medical University (CX2016-19)
- New Century Excellent Talents in University (1252-NCET-014)
- Science Foundation of Harbin Medical University (CX2016-19)
This publication has 24 references indexed in Scilit:
- MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow MicroenvironmentBioMed Research International, 2016
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategiesAdvanced Drug Delivery Reviews, 2015
- The Role of MicroRNAs in Ovarian CancerBioMed Research International, 2014
- MicroRNA signatures characterize multiple myeloma patientsLeukemia, 2011
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisProceedings of the National Academy of Sciences, 2008
- An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myelomaBMC Medical Genomics, 2008
- Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphomaBritish Journal of Haematology, 2008
- Multiple myelomaBlood, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Genetics and Cytogenetics of Multiple MyelomaCancer Research, 2004